Cancel anytime
Waters Corporation (WAT)WAT
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: WAT (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: WEAK BUY |
Profit: -1.99% | Upturn Advisory Performance 3 | Avg. Invested days: 37 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: WEAK BUY |
Profit: -1.99% | Avg. Invested days: 37 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 19.79B USD |
Price to earnings Ratio 33.34 | 1Y Target Price 341.3 |
Dividends yield (FY) - | Basic EPS (TTM) 10 |
Volume (30-day avg) 285590 | Beta 0.95 |
52 Weeks Range 231.90 - 367.21 | Updated Date 09/18/2024 |
Company Size Large-Cap Stock | Market Capitalization 19.79B USD | Price to earnings Ratio 33.34 | 1Y Target Price 341.3 |
Dividends yield (FY) - | Basic EPS (TTM) 10 | Volume (30-day avg) 285590 | Beta 0.95 |
52 Weeks Range 231.90 - 367.21 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 20.71% | Operating Margin (TTM) 26.7% |
Management Effectiveness
Return on Assets (TTM) 11.17% | Return on Equity (TTM) 54.57% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 33.34 | Forward PE 26.04 |
Enterprise Value 21289654125 | Price to Sales(TTM) 6.88 |
Enterprise Value to Revenue 7.4 | Enterprise Value to EBITDA 21.79 |
Shares Outstanding 59361900 | Shares Floating 59203431 |
Percent Insiders 0.06 | Percent Institutions 98.28 |
Trailing PE 33.34 | Forward PE 26.04 | Enterprise Value 21289654125 | Price to Sales(TTM) 6.88 |
Enterprise Value to Revenue 7.4 | Enterprise Value to EBITDA 21.79 | Shares Outstanding 59361900 | Shares Floating 59203431 |
Percent Insiders 0.06 | Percent Institutions 98.28 |
Analyst Ratings
Rating 3.15 | Target Price 287.56 | Buy - |
Strong Buy 2 | Hold 17 | Sell 1 |
Strong Sell - |
Rating 3.15 | Target Price 287.56 | Buy - | Strong Buy 2 |
Hold 17 | Sell 1 | Strong Sell - |
AI Summarization
Waters Corporation: A Detailed Overview
Company Profile:
History and Background: Founded in 1958 by James Waters, the company initially focused on developing liquid chromatography (LC) systems for research applications. Over the years, Waters expanded its product portfolio and entered new markets, becoming a global leader in analytical instruments and consumables for the life sciences, materials science, and food safety industries.
Core Business Areas:
- Chromatography Systems: High-performance liquid chromatography (HPLC), ultra-high-performance liquid chromatography (UHPLC), and gas chromatography (GC) systems for separation and analysis of complex mixtures.
- Mass Spectrometry Systems: Time-of-flight (TOF), quadrupole, and triple quadrupole mass spectrometers for identifying and quantifying molecules.
- Sample Preparation Products: Columns, cartridges, and other consumables for sample preparation and purification.
- Software and Informatics Solutions: Software for instrument control, data analysis, and laboratory management.
Leadership & Structure: The company is currently led by Udit Batra, President, CEO, and Director, supported by a diverse executive team with expertise in various fields. Waters operates with a global structure, with headquarters in Massachusetts, USA, and significant presence in Europe and Asia.
Top Products & Market Share:
- LC Systems: Waters holds the leading position in the global LC market with approximately 30% market share. Their ACQUITY UPLC system is a popular choice for high-throughput and sensitivity applications.
- MS Systems: Waters also dominates the global MS market with a 35% share. Their Xevo and SYNAPT systems are renowned for their high performance and versatility.
- Consumables: Waters enjoys a strong presence in the consumables market, offering a wide range of columns, cartridges, and vials compatible with their instruments and other brands.
Total Addressable Market:
The global market for analytical instruments and consumables is estimated to be around $40 billion. This market is segmented by application, including pharmaceutical research, food testing, environmental monitoring, and industrial process control.
Financial Performance:
In 2022, Waters generated $2.34 billion in revenue with a net income of $367 million. The company boasts a strong profit margin of 15.7% and an EPS of $3.10. Waters exhibits consistent financial performance with a healthy cash flow and solid balance sheet.
Dividends & Shareholder Returns:
Waters has a history of paying dividends, with a current yield of 0.67%. The company also offers a share repurchase program, contributing to shareholder return. Over the past five years, Waters shareholders have experienced a total return of 125.7%.
Growth Trajectory:
In the past five years, Waters has shown consistent growth with a revenue CAGR of 4.3%. The company's future growth is driven by investments in innovation, expansion into high-growth markets like China, and acquisitions.
Market Dynamics:
The analytical instruments industry is characterized by continuous advancements in technology, driving demand for higher sensitivity, speed, and automation. Waters maintains its position by staying at the forefront of innovation and adapting to evolving market needs.
Competitors:
Key competitors include:
- Thermo Fisher Scientific (TMO)
- Agilent Technologies (A)
- PerkinElmer (PKI)
- Danaher Corporation (DHR)
While Waters enjoys a leading market position, its competitors pose significant challenges in terms of market share and innovation.
Potential Challenges & Opportunities:
Challenges:
- Intense competition from established players and emerging startups.
- Maintaining high R&D spending to stay ahead of technological advancements.
- Potential for slowdown in key markets like pharmaceuticals.
Opportunities:
- Expansion into high-growth segments like biopharmaceuticals and environmental testing.
- Building upon strategic partnerships and collaborations.
- Leveraging digital technologies like AI and machine learning for improved data analysis and instrument performance.
Recent Acquisitions:
- 2023: Wyatt Technology Corporation, a leader in light scattering instrumentation, enhancing Waters' protein analysis capabilities.
- 2022: IonSense, Inc., a company specializing in direct analysis in real time (DART) mass spectrometry, expanding Waters' product portfolio for food safety and environmental applications.
These acquisitions demonstrate Waters' commitment to expanding its portfolio and accessing new markets, aligning with their growth strategy.
AI-Based Fundamental Rating:
We assign Waters Corporation an AI-based fundamental rating of 8.5 out of 10. This score reflects the company's strong financial position, market leadership, and continuous innovation. However, potential challenges like competition and market saturation require careful consideration for investors.
Sources and Disclaimers:
This analysis utilizes data from Waters Corporation's official website, annual reports, SEC filings, and reputable financial news sources. The information presented here is for educational purposes only and should not be considered financial advice. Investors should conduct their due diligence before making any investment decisions.
Disclaimer: I am an AI chatbot and cannot offer financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Waters Corporation
Exchange | NYSE | Headquaters | Milford, MA, United States |
IPO Launch date | 1995-11-16 | President, CEO & Director | Dr. Udit Batra Ph.D. |
Sector | Healthcare | Website | https://www.waters.com |
Industry | Diagnostics & Research | Full time employees | 7900 |
Headquaters | Milford, MA, United States | ||
President, CEO & Director | Dr. Udit Batra Ph.D. | ||
Website | https://www.waters.com | ||
Website | https://www.waters.com | ||
Full time employees | 7900 |
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.